Senti Biosciences, Inc. (SNTI)
SNTI Stock Price Chart
Explore Senti Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze SNTI price movements and trends.
SNTI Company Profile
Discover essential business fundamentals and corporate details for Senti Biosciences, Inc. (SNTI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 May 2021
Employees
34.00
Website
https://www.sentibio.comCEO
Timothy K. Lu
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications. The company's lead programs include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia (AML) cells, while sparing the healthy bone marrow; and SENTI-301, a multi-armed off-the-shelf CAR-NK cell therapy designed for the treatment of hepatocellular carcinoma (HCC). It also develops SENTI-401, a Logic Gated (NOT) off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer (CRC) cells, while sparing healthy cells in the body. The company was founded in 2016 and is based in South San Francisco, California.
SNTI Financial Timeline
Browse a chronological timeline of Senti Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 Mar 2026
Upcoming earnings on 13 Nov 2025
Earnings released on 7 Aug 2025
EPS came in at -$0.56 surpassing the estimated -$0.90 by +37.78%.
Earnings released on 6 May 2025
EPS came in at -$1.41 falling short of the estimated -$0.58 by -143.10%.
Earnings released on 20 Mar 2025
EPS came in at -$0.67 surpassing the estimated -$3.13 by +78.59%, while revenue for the quarter reached $5.86M , beating expectations by +109.14%.
Earnings released on 14 Nov 2024
EPS came in at -$6.31 .
Earnings released on 13 Aug 2024
EPS came in at -$2.45 .
Stock split effective on 18 Jul 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2024
EPS came in at -$2.60 .
Earnings released on 21 Mar 2024
EPS came in at -$4.20 falling short of the estimated -$0.23 by -1.73K%, while revenue for the quarter reached $333.00K , beating expectations by +11.00%.
Earnings released on 13 Nov 2023
EPS came in at -$2.50 surpassing the estimated -$4.80 by +47.92%, while revenue for the quarter reached $255.00K , missing expectations by -15.00%.
Earnings released on 11 Aug 2023
EPS came in at -$4.20 surpassing the estimated -$4.80 by +12.50%, while revenue for the quarter reached $937.00K , beating expectations by +87.40%.
Earnings released on 9 May 2023
EPS came in at -$4.20 surpassing the estimated -$4.80 by +12.50%, while revenue for the quarter reached $1.04M , beating expectations by +107.20%.
Earnings released on 22 Mar 2023
EPS came in at -$4.20 surpassing the estimated -$4.70 by +10.64%, while revenue for the quarter reached $59.00K , missing expectations by -87.45%.
Earnings released on 10 Nov 2022
EPS came in at -$3.80 surpassing the estimated -$5.20 by +26.92%, while revenue for the quarter reached $1.77M , beating expectations by +14.68%.
Earnings released on 15 Aug 2022
EPS came in at -$2.65 , while revenue for the quarter reached $1.11M .
Earnings released on 9 Aug 2022
EPS came in at -$2.70 , while revenue for the quarter reached $854.00K .
Earnings released on 7 Mar 2022
EPS came in at -$2.50 , while revenue for the quarter reached $543.00K .
Earnings released on 10 Nov 2021
EPS came in at -$2.61 , while revenue for the quarter reached $926.00K .
Earnings released on 6 Aug 2021
EPS came in at -$2.75 , while revenue for the quarter reached $778.00K .
Earnings released on 2 Jul 2021
EPS came in at -$0.00 , while revenue for the quarter reached $72.00K .
Earnings released on 31 Dec 2020
EPS came in at -$0.75 , while revenue for the quarter reached $2.00K .
SNTI Stock Performance
Access detailed SNTI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.